Most research has confirmed that Beclin1 has been evaluated as an important prognostic marker in several malignancies, and low expression of Beclin1 is associated with unfavorable prognosis in ESCC [49], colorectal cancer [50]and lung cancer [51]. This evidence concerns the gene BECN1 and lung cancer.